# Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

> **NCT06681051** · — · RECRUITING · sponsor: **TRB Chemedica AG** · enrollment: 84 (estimated)

## Conditions studied

- Tendinopathy

## Interventions

- **DEVICE:** OSTENIL® TENDON

## Key facts

- **NCT ID:** NCT06681051
- **Lead sponsor:** TRB Chemedica AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-25
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681051, "Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06681051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*